BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28974744)

  • 1. Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.
    Delanaye P; Warling X; Moonen M; Smelten N; Jouret F; Krzesinski JM; Maillard N; Pottel H; Cavalier E
    Sci Rep; 2017 Oct; 7(1):12623. PubMed ID: 28974744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone markers during acute burn care: Relevance to clinical practice?
    Rousseau AF; Damas P; Delanaye P; Cavalier E
    Burns; 2017 Feb; 43(1):176-181. PubMed ID: 27576929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
    J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
    [No Abstract]   [Full Text] [Related]  

  • 9. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
    Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
    Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
    Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC; Ma WY; Yu JC; Wu CC; Chu P
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Aerobic Exercise on Markers of Bone Metabolism of Overweight and Obese Patients With Chronic Kidney Disease.
    Gomes TS; Aoike DT; Baria F; Graciolli FG; Moyses RMA; Cuppari L
    J Ren Nutr; 2017 Sep; 27(5):364-371. PubMed ID: 28606422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
    J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.